Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the International Association of Physicians in AIDS Care

• Publication date

  2007-06-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1545109707300684PMID 17579125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

  2004cited by this paper
• Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

  2004cited by this paper
• Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999–2001

  2004cited by this paper
• Attenuated T-Lymphocyte Response to HIV Therapy in Individuals Receiving HMG-CoA Reductase Inhibitors

  2003cited by this paper
• Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.

  2003cited by this paper
• Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.

  2002cited by this paper
• The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

  2002cited by this paper
• Long-term persistence in use of statin therapy in elderly patients.

  2002cited by this paper
• Immunosuppressive effects of statins.

  2002cited by this paper
• Systemic T-cell activation in stable angina pectoris.

  2002cited by this paper
• Are early clinical effects of cholesterol lowering mediated through effects on inflammation?

  2002cited by this paper
• Effects of simvastatin and atorvastatin on inflammation markers in plasma

  2002cited by this paper
• Limited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced disease

  2002cited by this paper
• Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease

  2001cited by this paper
• Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks.

  2001cited by this paper
• Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients.

  2001cited by this paper
• Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

  2001cited by this paper
• Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

  2000cited by this paper
• Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.

  2000cited by this paper
• Inhibition of proinflammatory cytokine production by pravastatin.

  1999cited by this paper
• Cumulative risk for developing hyperlipidemia in HIV-infected patients treated with protease inhibitors

  1999cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• Immune system differences in men with hypo- or hypercholesterolemia.

  1997cited by this paper
• Lymphocyte T subset counts in children with elevated low-density lipoprotein cholesterol levels.

  1995cited by this paper

• A Systematic Review and Meta-Analysis on the Impact of Statin Treatment in HIV Patients on Antiretroviral Therapy

  2023cites this paper
• TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disorders.

  2019cites this paper
• Current use of statins reduces risk of HIV rebound on suppressive HAART

  2017cites this paper
• Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling

  2017cites this paper
• Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21

  2016cites this paper
• The Role of Statins in the Setting of HIV Infection

  2015cites this paper
• Randomized clinical trial of lovastatin in HIV-infected, HAART naïve patients (NCT00721305).

  2012cites this paper
• RandomizedclinicaltrialoflovastatininHIV-infected, HAART na€ive patients (NCT00721305)

  2012cites this paper
• Randomized clinical trial of lovastatin inHIV-infected, HAART na€ıve patients (NCT00721305)

  2012cites this paper
• Cholesterol, vitamin D and cardiovascular prevention in HIV patients treated with antiretroviral therapy.

  2011cites this paper
• Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study

  2011cites this paper
• HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons

  2011cites this paper
• Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.

  2011cites this paper
• Preconditioning, postconditioning, stunning and hibernation: towards an integrated insight into the mechanisms of hypoperfusion/reperfusion.

  2011cites this paper
• hypocholesterolemia blunts HAART effectiveness: a longitudinal study

  2010cites this paper
• Low cholesterol? Don't brag yet ... hypocholesterolemia blunts HAART effectiveness: a longitudinal study

  2010influential citation
• Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation.

  2008cites this paper